Durkacz was interim CEO by the board and Saeed as president FSD Pharma Inc. (Nasdaq: HUGE) (CSE:HUGE) In the statement, Durkacz stated, "The company now has the opportunity of a competent board of directors who bring with them very appropriate experience and expertise."